» Articles » PMID: 34608330

Obesity and Hyperinsulinemia Drive Adipocytes to Activate a Cell Cycle Program and Senesce

Abstract

Obesity is considered an important factor for many chronic diseases, including diabetes, cardiovascular disease and cancer. The expansion of adipose tissue in obesity is due to an increase in both adipocyte progenitor differentiation and mature adipocyte cell size. Adipocytes, however, are thought to be unable to divide or enter the cell cycle. We demonstrate that mature human adipocytes unexpectedly display a gene and protein signature indicative of an active cell cycle program. Adipocyte cell cycle progression associates with obesity and hyperinsulinemia, with a concomitant increase in cell size, nuclear size and nuclear DNA content. Chronic hyperinsulinemia in vitro or in humans, however, is associated with subsequent cell cycle exit, leading to a premature senescent transcriptomic and secretory profile in adipocytes. Premature senescence is rapidly becoming recognized as an important mediator of stress-induced tissue dysfunction. By demonstrating that adipocytes can activate a cell cycle program, we define a mechanism whereby mature human adipocytes senesce. We further show that by targeting the adipocyte cell cycle program using metformin, it is possible to influence adipocyte senescence and obesity-associated adipose tissue inflammation.

Citing Articles

The Anti-Aging Mechanism of Metformin: From Molecular Insights to Clinical Applications.

Zhang T, Zhou L, Makarczyk M, Feng P, Zhang J Molecules. 2025; 30(4).

PMID: 40005128 PMC: 11858480. DOI: 10.3390/molecules30040816.


Type 2 diabetes: a sacrifice program handling energy surplus.

Ye J, Yin J Life Metab. 2025; 3(6):loae033.

PMID: 39873003 PMC: 11748514. DOI: 10.1093/lifemeta/loae033.


Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone?.

Russo L, Babboni S, Andreassi M, Daher J, Canale P, Del Turco S Antioxidants (Basel). 2025; 14(1).

PMID: 39857433 PMC: 11763027. DOI: 10.3390/antiox14010099.


Myristoylated Eepd1 Enhances Lipolysis and Thermogenesis through PKA Activation to Combat Obesity.

Chen S, Wang Y, Zhou Q, Qian Q, Jiang Q, Liu C Nat Commun. 2025; 16(1):651.

PMID: 39809799 PMC: 11733280. DOI: 10.1038/s41467-025-56026-2.


Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.

PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.


References
1.
Arner P, Bernard S, Appelsved L, Fu K, Andersson D, Salehpour M . Adipose lipid turnover and long-term changes in body weight. Nat Med. 2019; 25(9):1385-1389. DOI: 10.1038/s41591-019-0565-5. View

2.
Ryden M, Arner P . Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism. J Intern Med. 2017; 282(3):220-228. DOI: 10.1111/joim.12641. View

3.
Spalding K, Arner E, Westermark P, Bernard S, Buchholz B, Bergmann O . Dynamics of fat cell turnover in humans. Nature. 2008; 453(7196):783-7. DOI: 10.1038/nature06902. View

4.
van Harmelen V, Skurk T, Rohrig K, Lee Y, Halbleib M, Aprath-Husmann I . Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord. 2003; 27(8):889-95. DOI: 10.1038/sj.ijo.0802314. View

5.
Hoffstedt J, Arner E, Wahrenberg H, Andersson D, Qvisth V, Lofgren P . Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia. 2010; 53(12):2496-503. DOI: 10.1007/s00125-010-1889-3. View